Qualitative analysis of safety reporting is critical for trial teams who must balance patient safety against administrative burden. Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents. This post refracts the July 30, 2026 PLOS One study through the lens of AI-enabled qualitative research, and shows how AI tools can speed synthesis, surface decision patterns, and support role-specific training for clinical trial staff.
Key Takeaways
According to PLOS One (published July 30, 2026), UK trials unit staff described safety-reporting decisions as “walking on a tightrope” between risk-proportionate efficiency and risk-averse over-reporting, and they identified clarity, training, and knowledge sharing as primary solutions (PLOS One).
The PLOS One study gives concrete, actionable priorities that AI-enabled qualitative research can accelerate: identify recurring decision points, extract examples for training, and quantify where duplication wastes time.
What happened and how the study was done
PLOS One conducted four online focus groups between 01-July-2024 and 04-March-2025 to explore barriers and solutions to efficient safety reporting in UK academic CTUs.
PLOS One reported on July 30, 2026 that 23 CTU staff attended and that transcripts were analysed using Reflexive Thematic Analysis to generate one over-arching theme and five subthemes.
PLOS One reported on July 30, 2026 that participants described practical barriers: uncertainty about consequences, bureaucratic red-tape, competing stakeholder demands, lack of clarity and transparency, and variable levels of knowledge and experience.
PLOS One included direct participant quotes such as: "Generally, you’ve got to balance what you need to collect in terms of safety reporting and in terms of what’s needed to monitor the safety of the drug" (Participant 16, FG3), and "It feels difficult and there is always that element of anxiety that you’ve got it wrong" (Participant 20, FG4).
Findings Snapshot
| Date / Event | Metric | Value (reported) | Implication |
|---|---|---|---|
| 01-Jul-2024 to 04-Mar-2025 | Focus groups | 4 online sessions | Rich qualitative data collected across roles and CTUs |
| July 30, 2026 | Participants | 23 CTU staff | Practical, operational perspectives on safety reporting |
| July 30, 2026 | CTU coverage | 10 of 52 UK CTUs | Findings transferable across similar academic units |
| July 30, 2026 | Experience | Mean 13.3 years (SD 9.5) | Participants bring deep operational knowledge |
| 28-Apr-2026 | Regulatory change | New UK clinical trials regulations in force | Reduces duplicative reporting to REC, clarifies risk categories |
Implications for clinical trial teams
Clinical trial teams should prioritize clearer guidance, role-specific training, and structured knowledge-sharing to enable risk-proportionate safety reporting, according to PLOS One (published July 30, 2026).
- Trial managers: document decision rules and early stakeholder agreements to avoid conservative over-reporting (PLOS One, July 30, 2026).
- Sponsors and CROs: align protocol-level reporting templates to reduce duplication and double-entry across portals (PLOS One, July 30, 2026).
- Regulators and educators: provide case studies and rapid-response FAQs so that staff can justify decisions without excessive anxiety (PLOS One, July 30, 2026).
- Quality leads: embed Patient Reported Outcome Measures so low-grade toxicities are captured when relevant, as recommended in ICH E6 (R3) guidance (ICH E6 (R3) guideline).
How Evidano Helps
Problem: Slow synthesis of qualitative evidence
Solution: Use Evidano to ingest focus-group transcripts, automatically generate thematic maps, and quantify code frequency across subgroups.
Evidano is an AI-powered qualitative data analysis platform that helps researchers analyze interviews, open-ended surveys, and documents. See the Evidano features page for relevant capabilities.
Problem: Training needs lack concrete examples
Solution: Use Evidano to extract verbatim excerpts and cluster decision examples by context, then export curated case-study packs for role-specific training.
Evidano can pair extracted quotes with coded rationale so trainers can show not just what was done but why, accelerating the "monkey-see-monkey-do" learning participants requested in PLOS One (published July 30, 2026).
Problem: Time lost to transcription and PII redaction
Solution: Use Evidano’s transcription features to produce cleaned, pseudonymised transcripts with a custom dictionary and PII redaction, then run thematic and co-occurrence network analyses.
For teams that already use recorded focus groups like the PLOS One study, Evidano reduces manual cleaning time and produces searchable, auditable outputs compatible with training and regulatory needs. See Evidano speech-to-text.
Problem: Need for AI chat over evidence
Solution: Use Evidano’s AI chat over your project documents to ask natural-language questions, retrieve supporting quotes, and create templated guidance for investigators and sites.
Evidano’s platform supports rapid, verifiable answers that teams can use to justify risk-proportionate choices during inspections or sponsor queries. See Evidano AI chatbot for examples.
FAQ: qualitative analysis of safety reporting
What were the main barriers to efficient safety reporting identified by the PLOS One study?
Answer: The main barriers were uncertainty about consequences, bureaucratic red-tape, competing stakeholder demands, lack of clarity and transparency, and varying levels of knowledge and experience (PLOS One, July 30, 2026).
The PLOS One study synthesised these into one over-arching theme, “Walking on a tightrope: Making justifiable decisions, ” which captures the tension between under- and over-reporting.
Did the PLOS One study measure how new UK regulations changed workload?
Answer: No, the PLOS One study did not measure post-regulation workload because focus groups occurred before and during regulatory change; the paper notes the new UK clinical trials regulations came into force on 28-Apr-2026 (PLOS One, July 30, 2026).
PLOS One recommends follow-up work to determine whether the April 28, 2026 legislative changes actually reduced duplication and uncertainty in practice.
How can qualitative AI tools help implement risk-proportionate reporting?
Answer: Qualitative AI tools speed thematic synthesis, surface recurring decision examples, and quantify where guidance is inconsistent, enabling targeted training and clearer SOPs.
PLOS One (July 30, 2026) participants asked for case studies and practical templates; AI-enabled platforms can generate those directly from transcripts and shared documents.
Are the PLOS One study results generalisable beyond oncology-focused CTUs?
Answer: The PLOS One authors note transferability rather than strict generalisability because participants were weighted toward oncology and academic trials, though many safety-reporting requirements are universal (PLOS One, July 30, 2026).
The study covered 10 of 52 UK CTUs and a mean participant experience of 13.3 years, which supports relevance to similar academic trials units but underlines the value of wider replication.
Conclusion & Next Steps
The PLOS One study (published July 30, 2026) shows that clearer guidance, targeted training, and shared case studies are the most practical levers to make safety reporting more efficient for UK academic CTUs.
AI-enabled qualitative research can accelerate each of these levers by extracting decision examples, quantifying where teams diverge, and producing role-specific learning packs.
If your team wants to convert focus-group evidence into training-ready outputs and audit-grade thematic analyses, Try Evidano for free.